Development and validation of insulin-like growth factor-1 score to assess hepatic reserve in hepatocellular carcinoma (Q33859804)

29 July 2017

Development and validation of insulin-like growth factor-1 score to assess hepatic reserve in hepatocellular carcinoma (English)

1 reference

29 July 2017

hepatocellular carcinoma

1 reference

6

Jean-Nicolas Vauthey

0 references

James Lewis Abbruzzese

18

object named as

James L Abbruzzese

1 reference

29 July 2017

Ahmed O Kaseb

1

1 reference

29 July 2017

Lianchun Xiao

2

1 reference

29 July 2017

Manal M Hassan

3

1 reference

29 July 2017

Young Kwang Chae

4

1 reference

29 July 2017

Ju-Seog Lee

5

1 reference

29 July 2017

Sunil Krishnan

7

1 reference

29 July 2017

Sheree Cheung

8

1 reference

29 July 2017

Hesham M Hassabo

9

1 reference

29 July 2017

Thomas Aloia

10

1 reference

29 July 2017

Claudius Conrad

11

1 reference

29 July 2017

Steven A Curley

12

1 reference

29 July 2017

John M Vierling

13

1 reference

29 July 2017

Prasun Jalal

14

1 reference

29 July 2017

Kanwal Raghav

15

1 reference

29 July 2017

Michael Wallace

16

1 reference

29 July 2017

Asif Rashid

17

1 reference

29 July 2017

Robert A Wolff

19

1 reference

29 July 2017

Jeffrey S Morris

20

1 reference

29 July 2017

language of work or name

English

0 references

publication date

9 May 2014

1 reference

Journal of the National Cancer Institute

29 July 2017

1 reference

29 July 2017

106

1 reference

29 July 2017

5

1 reference

Clinical and prognostic implications of plasma insulin-like growth factor-1 and vascular endothelial growth factor in patients with hepatocellular carcinoma

29 July 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4085880

MELD score, insulin-like growth factor 1 and cytokines on bone density in end-stage liver disease

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4085880

I-CLIP: improved stratification of advanced hepatocellular carcinoma patients by integrating plasma IGF-1 into CLIP score

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4085880

Pretreatment assessment of hepatocellular carcinoma: expert consensus statement

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4085880

Design and endpoints of clinical trials in hepatocellular carcinoma.

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4085880

Management of hepatocellular carcinoma

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4085880

Expression of albumin, IGF-1, IGFBP-3 in tumor tissues and adjacent non-tumor tissues of hepatocellular carcinoma patients with cirrhosis

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4085880

Assessment of the prognosis of cirrhosis: Child-Pugh versus MELD.

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4085880

Clinical significance of serum IGF-I, IGF-II and IGFBP-3 in liver cirrhosis

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4085880

The insulin-like growth factor system and cancer

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4085880

Model for end-stage liver disease (MELD) and allocation of donor livers

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4085880

A model to predict poor survival in patients undergoing transjugular intrahepatic portosystemic shunts

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4085880

Prospective study of colorectal cancer risk in men and plasma levels of insulin-like growth factor (IGF)-I and IGF-binding protein-3.

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4085880

Plasma insulin-like growth factor-I and prostate cancer risk: a prospective study

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4085880

Insulin-like growth factors and their binding proteins: biological actions

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4085880

Transection of the oesophagus for bleeding oesophageal varices

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4085880

Pretreatment assessment of hepatocellular cancer: expert consensus conference

28 July 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJU088

MELD scoring system is useful for predicting prognosis in patients with liver cirrhosis and is correlated with residual liver function: a European study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJU088

Plasma levels of insulin-like growth factor-I and lung cancer risk: a case-control analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJU088

Association of circulating insulin-like growth factor 1 with hepatocellular carcinoma: one cross-sectional correlation study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJU088

Association between hepatic steatosis and serum IGF1 and IGFBP-3 levels in a population-based sample.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJU088

Hepatic osteodystrophy and liver cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJU088

Insulin-like growth factor-I and the liver.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJU088

Insulin-like growth factor I correlates with MELD and returns to normal level after liver transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJU088

Serum IGF-1, IGF-2 and IGFBP-3 as parameters in the assessment of liver dysfunction in patients with hepatic cirrhosis and in the diagnosis of hepatocellular carcinoma

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4085880

Can the MEGX test and serum bile acids improve the prognostic ability of Child-Pugh's score in liver cirrhosis?

29 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4085880

Circulating concentrations of insulin-like growth factor I and risk of breast cancer

29 October 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJU088

REMOTE RESULTS OF PORTAL SURGERY IN LIVER CIRRHOSIS

21 January 2018

1 reference

12 December 2020

Insulin-like growth factor 1 in hepatocellular carcinoma and metastatic liver cancer in men

1 reference

12 December 2020

Serum concentrations of human insulin-like growth factor-1 and levels of insulin-like growth factor-binding protein-5 in patients with nonalcoholic fatty liver disease: association with liver histology

1 reference

12 December 2020

Assessment of pretransplant prognosis in patients with cirrhosis

1 reference

12 December 2020

Circulating growth hormone and insulin-like growth factor-I in nonalcoholic liver cirrhosis with or without superimposed hepatocarcinoma: evidence of an altered circadian rhythm

1 reference

12 December 2020

IL-6 and IGF-1 are independent prognostic factors of liver steatosis and non-alcoholic steatohepatitis in morbidly obese patients

1 reference

12 December 2020

Growth hormone-stimulated IGF-1 generation in cirrhosis reflects hepatocellular dysfunction

1 reference

12 December 2020

Identifiers

DOI

10.1093/JNCI/DJU088

1 reference

29 July 2017

1 reference

29 July 2017

1 reference